InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by GLAXOSMITHKLINE PLC. Officer active across 4 companies, notably Innoviva, Inc.. Cumulatively, 6 disclosures have been published. Total volume traded: €641.4m. The latest transaction was disclosed on 20 May 2021 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations6 total
30,253,189 shares
Common Stock
SEC:0001387131-21-006822·
30,253,189 shares
Common Stock
SEC:0001387131-21-006822:0·
€321m32,005,260 shares@ €10.0201100.0% of flow
Common Stock
SEC:0001387131-21-006039·
€321m32,005,260 shares@ €10.020119.78% mcap100.0% of flow
Common Stock
SEC:0001387131-21-006039:0·
6 of 6 declarations
About GLAXOSMITHKLINE PLC
GLAXOSMITHKLINE PLC is a director and insider, involved with Innoviva, Inc., Lyell Immunopharma, Inc., and CVRx, Inc.
